S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Steven Cohen’s THC Holdings & Trades

First Buy
Q4 2014
Duration Held
38 Quarters
Largest Add
Q3 2018
+595,552 Shares
Current Position
473,834 Shares
$96.21 M Value

Steven Cohen's THC Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 473,834 shares of Tenet Healthcare Corporation (THC) worth $96.21 M, representing 0.16% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 38 quarters.

Based on 13F filings, Steven Cohen has maintained a strategic position in THC, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2018, adding 595,552 shares. Largest reduction occurred in Q1 2019, reducing 821,100 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Tenet Healthcare Corporation (THC) Holding Value Over Time

Track share changes against reported price movement

Quarterly Tenet Healthcare Corporation (THC) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2014 +54,500 New Buy 54,500 $50.68
Q1 2015 -54,500 Sold Out 0 $0.00
Q2 2015 +4,000 New Buy 4,000 $58.00
Q3 2015 +458,600 Add 11465.00% 462,600 $36.92
Q4 2015 -462,600 Sold Out 0 $0.00
Q3 2016 +415,400 New Buy 415,400 $22.66
Q4 2016 -410,100 Reduce 98.72% 5,300 $14.91
Q1 2017 -5,300 Sold Out 0 $0.00
Q3 2017 +282,435 New Buy 282,435 $16.43
Q4 2017 -47,660 Reduce 16.87% 234,775 $15.16
Q1 2018 +9,525 Add 4.06% 244,300 $24.25
Q2 2018 -244,300 Sold Out 0 $0.00
Q3 2018 +595,552 New Buy 595,552 $28.46
Q4 2018 +225,548 Add 37.87% 821,100 $17.14
Q1 2019 -821,100 Sold Out 0 $0.00
Q2 2019 +6,000 New Buy 6,000 $20.67
Q3 2019 -6,000 Sold Out 0 $0.00
Q4 2019 +23,500 New Buy 23,500 $38.04
Q1 2020 -23,500 Sold Out 0 $0.00
Q1 2021 +188,600 New Buy 188,600 $52.00
Q2 2021 -27,500 Reduce 14.58% 161,100 $66.99
Q3 2021 -130,668 Reduce 81.11% 30,432 $66.44
Q4 2021 +70,368 Add 231.23% 100,800 $81.69
Q1 2022 +211,337 Add 209.66% 312,137 $85.96
Q2 2022 +255,363 Add 81.81% 567,500 $52.56
Q3 2022 -567,500 Sold Out 0 $0.00
Q4 2022 +127,407 New Buy 127,407 $48.79
Q1 2023 +135,120 Add 106.05% 262,527 $59.42
Q2 2023 +559,477 Add 213.11% 822,004 $81.38
Q3 2023 -135,180 Reduce 16.45% 686,824 $65.89
Q4 2023 -282,518 Reduce 41.13% 404,306 $75.57
Q1 2024 +49,382 Add 12.21% 453,688 $105.11
Q2 2024 -117,429 Reduce 25.88% 336,259 $133.03
Q3 2024 +106,690 Add 31.73% 442,949 $166.20
Q4 2024 -442,949 Sold Out 0 $0.00
Q1 2025 +108,580 New Buy 108,580 $134.50
Q2 2025 +5,755 Add 5.30% 114,335 $176.00
Q3 2025 +359,499 Add 314.43% 473,834 $203.04

Steven Cohen's Tenet Healthcare Corporation Investment FAQs

Steven Cohen first purchased Tenet Healthcare Corporation (THC) in Q4 2014, acquiring 54,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Tenet Healthcare Corporation (THC) for 38 quarters since Q4 2014.

Steven Cohen's largest addition to Tenet Healthcare Corporation (THC) was in Q3 2018, adding 595,552 shares worth $16.95 M.

According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 473,834 shares of Tenet Healthcare Corporation (THC), valued at approximately $96.21 M.

As of the Q3 2025 filing, Tenet Healthcare Corporation (THC) represents approximately 0.16% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Tenet Healthcare Corporation (THC) was 822,004 shares, as reported at the end of Q2 2023.